Literature DB >> 1702678

Serum granulocyte colony-stimulating factor levels in chronic neutropenia of infancy.

Y Mizuno1, T Hara, M Nagata, F Omori, K Shimoda, S Okamura, Y Niho, K Ueda.   

Abstract

Eight infants with chronic neutropenia ranging in age from 1 to 13 months were studied for serum granulocyte colony-stimulating factor (G-CSF) levels. Serum G-CSF levels were elevated, especially when peripheral blood absolute neutrophil counts (ANC) were under 500/microliter in seven patients with autoimmune neutropenia. On the other hand, in a patient with congenital agranulocytosis (Kostmann type), G-CSF levels were below the sensitivity of the assay (less than 50 pg/ml) despite severe neutropenia (less than 100/microliter).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702678     DOI: 10.3109/08880019009033415

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  3 in total

1.  Autoimmune neutropenia of infancy.

Authors:  E G Lyall; G F Lucas; O B Eden
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

2.  A novel mutation in the juxtamembrane intracellular sequence of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a patient with severe congenital neutropenia augments GCSF proliferation activity but not through the MAP kinase cascade.

Authors:  Toshihiro Yokoyama; Seiichi Okamura; Yoshinobu Asano; Kenjirou Kamezaki; Akihiko Numata; Haruko Kakumitsu; Koutarou Shide; Hitoshi Nakashima; Kanaji Taisuke; Yuichi Sekine; Yumi Mizuno; Jun Okamura; Tadashi Matsuda; Mine Harada; Niho Yoshiyuki; Kazuya Shimoda
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

3.  Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene.

Authors:  M H Hermans; C Antonissen; A C Ward; A E Mayen; R E Ploemacher; I P Touw
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.